
PlexoBio is a life sciences marketplace and advisory platform focused on accelerating drug discovery and preclinical research. They connect pharmaceutical and biotech companies with high-quality, ethically sourced preclinical models (such as organ-on-a-chip, 3D cell cultures, in silico models, and tumor models) and human biospecimens. Their business model centers around providing a streamlined marketplace for these resources, complemented by expert advisory support. PlexoBio aims to improve research accuracy, reduce timelines, and decrease reliance on animal testing by facilitating access to advanced, human-relevant research tools. While their digital platform is under development, they offer personalized support to help clients navigate and source these critical research components, with plans to integrate AI and blockchain for enhanced data management and efficiency. They target biotech, pharmaceutical, and biopharma industries, as well as research institutions and academic labs.

PlexoBio is a life sciences marketplace and advisory platform focused on accelerating drug discovery and preclinical research. They connect pharmaceutical and biotech companies with high-quality, ethically sourced preclinical models (such as organ-on-a-chip, 3D cell cultures, in silico models, and tumor models) and human biospecimens. Their business model centers around providing a streamlined marketplace for these resources, complemented by expert advisory support. PlexoBio aims to improve research accuracy, reduce timelines, and decrease reliance on animal testing by facilitating access to advanced, human-relevant research tools. While their digital platform is under development, they offer personalized support to help clients navigate and source these critical research components, with plans to integrate AI and blockchain for enhanced data management and efficiency. They target biotech, pharmaceutical, and biopharma industries, as well as research institutions and academic labs.